Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Beginning Cash Balance: 2020-2025

Historic Beginning Cash Balance for Cellebrite DI (CLBT) over the last 4 years, with Sep 2025 value amounting to $179.2 million.

  • Cellebrite DI's Beginning Cash Balance rose 67.57% to $179.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $614.2 million, marking a year-over-year increase of 12.89%. This contributed to the annual value of $189.5 million for FY2024, which is 116.23% up from last year.
  • According to the latest figures from Q3 2025, Cellebrite DI's Beginning Cash Balance is $179.2 million, which was down 6.49% from $191.7 million recorded in Q1 2025.
  • Cellebrite DI's 5-year Beginning Cash Balance high stood at $191.7 million for Q1 2025, and its period low was $84.6 million during Q4 2022.
  • In the last 3 years, Cellebrite DI's Beginning Cash Balance had a median value of $136.3 million in 2024 and averaged $137.5 million.
  • Per our database at Business Quant, Cellebrite DI's Beginning Cash Balance surged by 269.45% in 2021 and then slumped by 46.51% in 2022.
  • Cellebrite DI's Beginning Cash Balance (Quarterly) stood at $109.9 million in 2021, then fell by 23.04% to $84.6 million in 2022, then skyrocketed by 62.08% to $137.1 million in 2023, then dropped by 0.52% to $136.3 million in 2024, then surged by 67.57% to $179.2 million in 2025.
  • Its last three reported values are $179.2 million in Q3 2025, $191.7 million for Q1 2025, and $136.3 million during Q4 2024.